Navigation Links
Mercator MedSystems Appoints Neil Desai, Ph.D., to Board of Directors
Date:2/14/2011

SAN LEANDRO, Calif., Feb. 14, 2011 /PRNewswire/ -- Mercator MedSystems, Inc., a privately held medical technology company focused on treating drug-resistant hypertension, announced today that Neil P. Desai, Ph.D. was elected to its Board of Directors. Dr. Desai has an extensive background in drug-delivery and global development and holds over 100 patents in the field. Prior to the acquisition of Abraxis Bioscience, Inc. (ABI), by Celgene Corporation in late 2010, he was Senior Vice-President of Global Research and Development for ABI where he was responsible for the development of ABI's proprietary product pipeline and intellectual property portfolio. He is presently Vice-President of Strategic Platforms at Celgene Corporation.

"Dr. Desai's extensive experience in drug development, global clinical research, and commercialization in an entrepreneurial environment is a perfect addition to Mercator's Board as we move to the next development stage of our unique approach to treating drug-resistant hypertension," said Thomas M. Loarie, Executive Chairman of Mercator MedSystems, Inc. Loarie also noted that this came at an ideal time with investor and strategic interest growing in hypertension treatments following the recent acquisition of Ardian, Inc., by Medtronic, Inc.

"I have been working with Mercator for over three years on collaborations using products developed by Abraxis so I have had a front row seat observing the development of their proprietary site-specific drug delivery platform," said Dr. Neil Desai. He added, "It's an exciting time in the evolution of Mercator and I am delighted to become a contributor."

Last year, pre-clinical data were presented on Mercator's therapeutic approach to drug-resistant hypertension and clinical data were presented on Athersys' use of Mercator's technology to deliver stem cells post-myocardial infarction at the 2010 Transcatheter Cardiovascular Therapeutics Conference in Washington, D.C.

About Mercator MedSystems, Inc.

Mercator MedSystems, Inc., based in San Leandro, Calif., is a privately held medical technology company focused on commercializing catheter-guided, microfluid infusion systems for site-specific delivery of therapeutic agents for applications in hypertension, cardiovascular disease, oncology and regenerative medicine.


'/>"/>
SOURCE Mercator MedSystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Relievant Medsystems Announces Completion of $20 Million Financing
2. Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing
3. Plato BioPharma, Inc Appoints New Board Member
4. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
5. SYNARC Appoints Ciaran Cooper as Vice President, Business Development
6. Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
7. Unilife Appoints Dr. Ramin Mojdeh as Chief Operating Officer
8. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
9. AssureRx Appoints Senior Executives in Key Roles to Drive Company Growth
10. Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics
11. Sysmex America Appoints Vice President of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the ... ound care market in Israel ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment ...
(Date:2/24/2017)... and Markets has announced the addition of the "Hemophilia Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Hemophilia ... market? What are the unit prices and annual treatment ...
(Date:2/24/2017)... 24, 2017 Medical information groups within ... their self-service capabilities to manage inquiries from external ... New research from consulting leader Best Practices, ... self-service website portals where HCPs can sign on ... of many findings to emerge from the new ...
Breaking Medicine Technology:
(Date:2/26/2017)... , ... February 26, 2017 , ... ... for entries to the 7th Edition of International Social Design Awards. , ... Professionals, Product Designers, System Designers, Governments and Institutions worldwide with realized projects and ...
(Date:2/26/2017)... Philadelphia, PA (PRWEB) , ... February 26, 2017 , ... ... products and services with Pay-For-Performance B2B Marketing. B2B Sellers will now only pay for ... , Robert Hennessey, the founder of IndustryArchive.Org, said, “Given the new reality that B2B ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... disease (PD) in persons with a specific LRRK2 mutation, according to a study ... Previous studies have provided evidence of a link between pesticides and incidence of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age is ... University predict that 47 percent of all jobs in the United States may be ... “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is drawing to ...
Breaking Medicine News(10 mins):